Biobanks, an under used resource

Save this PDF as:
 WORD  PNG  TXT  JPG

Size: px
Start display at page:

Download "Biobanks, an under used resource"

Transcription

1 Biobanks, an under used resource Mark Divers Karolinska Institutet Biobank och BBMRI.se Vinnova VR workshop, Stockholm, juni 2012 Forskningsinfrastruktur för industriella innovationer But biobanking is hot! Big interest >$1B technology spend per year Big population studies appeared Hunt, decode, UK Biobank, LifeGene, LifeLines, Kadoorie Big analysis transformation Genetic and protein technologies Big discussion Many hopes, many fears 2 Growing impact on medical research Huge public health opportunity 1

2 What is a biobank? Organiserad collection of biological samples Often human Archived long term Frozen: 20, 80, 190 C Searchable & accessible Samples and data Used for research, development and healthcare Described as gold mine! Regulated by law MD1 Biobank landscape of Sweden 579 Biobanks 2

3 Biobank landscape of Sweden for healthcare Tissue 114 M sampels Cells 28, 7 M Blood/plasma Serum DNA/RNA Bone Others Biobank landscape of Sweden for research Blood/Plasma 4,2 M Serum 2,3 M DNA/RNA Tissue Urin Salivia Other

4 The biobanks of KI and BBMRI.se are a rich source of samples: 150 studies Population cohorts TwinGene, LifeGene, EpiHealth Karma, Stockhom 2 Disease based studies Cancer CV Neurological Inflammatory Immunological Quality registers A good climate for biobank-based research in Sweden Well characterised population personal number system systematic registries Track record Eg Swedish Twin Registry TwinGene Large population cohorts emerged 2009 LifeGene, EpiHealth Long term research impact Public support 4

5 But challenges too Fragmentation Organisational Logistic Economic Complex ethico legal landscape EU BBMRI initiative: our chance to create biobanks of the future Technology: test and apply the best! Network: connect modern biobanks! Vision: 300 biobanks throughout EU Harmonise: evolve common standards! Add big public health value! Swedish Science Research Council and KI fund BBMRI.se for 5 years 5

6 large-scale Swedish Biobanking (SSB); a service for big national studies Some biobank accounts May 2012 Total KIBB BBMRI.se # studies # samples # donors # DNA samples # withdrawals > > >

7 Creating a BBMRI.se national network Progressive build up in medical universities Goteborg node launch Jan st project: Scapis Malmö node Co ordinated: Sample format Data format Processes Equipment & consumables Access and use launch 1Q2012 1st projects: EpiHealth, MKC, MFM Linköping, Umeå, Uppsala to come Linköping launch 1H2013? Projects identified Starting co ordination with healthcare biobanking 13 Unifying Swedish biobanks further University + Healthcare biobanks National common infrastructure VR SKL declaration Regional partnerships, eg Uppsala biobank Göteborg Region Skåne KI SLL 7

8 Why are we biobanking?... Study publications to advance medical research! Combine with modern bio analysis Systematic Statistical power Huge potential for public health GALLSTEN 4 PAIN 2 BAMSE 8 SCALE 15 Ekonomiskt beteende 2 TwinGene & Euroclot 13 HARMONY & SATSA 12 KTS 1 CAPS 40 Totalt 97 Emerging highlights Multiple Sclerosis TwinGene Broad Influenza Like Illnesses Prostate Cancer What is the value of biobanking?... Multiple Sclerosis research gives a great example* ~17K MS cases in Sweden Many represented in our biobank New therapy, Tysabri Monoclonal antibody Very effective, very expensive Serious side effects in some (polyoma viral cross reacton) Screen MS biobank for polyoma virus Save big drug cost (200KKr/patient/yr) Save some lives, improve others Match a good drug to the right patients *T Olsson et al /New_Tysabri_label_to_personalise_treatment.aspx 16 8

9 Biobanking adds big value Mark Divers Clinical practice Better screening, diagnosis and treatment match Health economy Better public health for lower cost eg HPV, MS Drug development Matching patients to treatments eg MS, HIV, HPV Ethical credibility Increased trust and support eg HPV Biobanks for industrial innovation? Discovery & Development Pharmaceuticals Biomarkers Patient subtyping Metabolites Safety profiling Diagnostics 9

10 The BBMRI Crew Joakim Dillner Jan-Eric Litton Mats Hansson Göran Hallmans Ulf Landegren Joakim Galli Lars-Olof Hansson Joyce Carlsson Lisen Arnheim-Dahlström Sofie Pettersson Martin Fransson Loreana Norlin Maria Anderberg The LifeGene Crew including Jens Mattsson Kicki Kjaergaard Mats Thurman Camilla Björk Thomas Bergman Acknowledgements Lab Operations Carita Rask Jaspal Singh Cecilia Agardh Peter Arnerlöv Anci Carman Pia Hillelson Camilla Lagerberg Vian Osman Amina Said Anette Selander Johanna Smith Siwonne Andersson Emma Ridell William Day Valentina Novak Karin Lindqvist The Biobank Crew Biobank IT Eva Büren Staffan Bergh Jonas Birgersson Ulrika Bohlin Jesper Lind Johan Stenninger José Tapia Anni Åsberg Niclas Ahlin Biobank Development Gunnel Tybring Customer Relations Tove Rylander-Rudqvist Cecilia Björkdahl Quality Anette Petersson Mirja Larsson Project coordination Anders Brinne KI Henrik Grönberg Per Hall Nancy Pedersen Rune Franson Per Spångeus More info

Managing and Using a Biobank in Sweden

Managing and Using a Biobank in Sweden How can the Material be used by Researchers in an Optimal Way Managing and Using a Biobank in Sweden March 19, 2013 Gunnel Tybring, Gunnel PhD, Tybring, PhD, Assoc Professor Assoc PhD, Assoc Professor

More information

The birth of the population-based cohort studies in preventive medicine From Framingham to Värmland

The birth of the population-based cohort studies in preventive medicine From Framingham to Värmland EpiScania Symposium Medicon Village, Lund 2 nd September 2015 The birth of the population-based cohort studies in preventive medicine From Framingham to Värmland Peter M Nilsson, MD, PhD Department of

More information

Information for patients and the public and patient information about DNA / Biobanking across Europe

Information for patients and the public and patient information about DNA / Biobanking across Europe Information for patients and the public and patient information about DNA / Biobanking across Europe BIOBANKING / DNA BANKING SUMMARY: A biobank is a store of human biological material, used for the purposes

More information

The Danish Biobank System a unique resource for biomedical research and development

The Danish Biobank System a unique resource for biomedical research and development The Danish Biobank System a unique resource for biomedical research and development Professor Stephen Hamilton-Dutoit Chair of Pathology, Aarhus University Denmark Denmark a great little country for biobank

More information

Blood Biobanking Chances and Risks. The Bavarian Red Cross Blood Donor Biobank

Blood Biobanking Chances and Risks. The Bavarian Red Cross Blood Donor Biobank Blood Biobanking Chances and Risks The Bavarian Red Cross Blood Donor Biobank EORTC-NCI-ASCO Meeting - November 2007 Outline Types of biobanking Why blood biobanking? Why blood banks? Why the Bavarian

More information

Centre for Biomarker Research in Medicine. COMET Competence Centre for Excellent Technologies

Centre for Biomarker Research in Medicine. COMET Competence Centre for Excellent Technologies Centre for Biomarker Research in Medicine COMET Competence Centre for Excellent Technologies Why Biomarker Research? early diagnosis, often before manifestation identification of at-risk patients for new

More information

#14 IN THIS ISSUE. #14 October 2014

#14 IN THIS ISSUE. #14 October 2014 #14 IN THIS ISSUE Editorial 2 BBMRI.se Communication Plan and LinkedIn Group 3 Sharing is ethical! 3 Interview with Anders Johansson about a new biobank-based project in Umeå 4 Meeting report HOBB2014

More information

MEDIA RELEASE. Embargoed until 10:00 9 th November 2014

MEDIA RELEASE. Embargoed until 10:00 9 th November 2014 MEDIA RELEASE Embargoed until 10:00 9 th November 2014 National Ovarian Cancer Research Strategy Launch For the First Time Critical Pathways Mapped to Better Care and Survival Rates for One of Australia

More information

Genetic Alliance BioBank: A Virtual Tour of Registry Solutions to Accelerate Research February 22, 2010

Genetic Alliance BioBank: A Virtual Tour of Registry Solutions to Accelerate Research February 22, 2010 Genetic Alliance BioBank: A Virtual Tour of Registry Solutions to Accelerate Research February 22, 2010 Liz Horn Genetic Alliance Posted in the Resource Repository at: http://www.resourcerepository.org/documents/1872/geneticalliancebiobank:avirtualto

More information

Guidelines for health professionals about DNA / Biobanking in Europe

Guidelines for health professionals about DNA / Biobanking in Europe Guidelines for health professionals about DNA / Biobanking in Europe BIOBANKING SUMMARY A "biobank" is a: "service unit, non-profit organization for the collection and preservation of biological material

More information

Attacking the Biobank Bottleneck

Attacking the Biobank Bottleneck Attacking the Biobank Bottleneck Professor Jan-Eric Litton BBMRI-ERIC BBMRI-ERIC Big Data meets research biobanking Big data is high-volume, high-velocity and highvariety information assets that demand

More information

Data integration and modelling in health sciences Science as a conversation across borders

Data integration and modelling in health sciences Science as a conversation across borders Open data key to the future Helsinki 2011-11-01 Data integration and modelling in health sciences Science as a conversation across borders Juni Palmgren Karolinska Institutet and FIMM, Helsinki University

More information

The Energy Systems Program Post graduate school and research program

The Energy Systems Program Post graduate school and research program The Energy Systems Program Post graduate school and research program Mats Söderström, Program director Magnus Karlsson, Director of postgraduate studies Head Sponsor: Understanding energy systems, their

More information

LeGrand Tour West Coast Adventure Race Stockholm Extreme 1-2 of May 6-7 of June 30-31 of August Rank Points Class Rank Points Class Rank Points Class

LeGrand Tour West Coast Adventure Race Stockholm Extreme 1-2 of May 6-7 of June 30-31 of August Rank Points Class Rank Points Class Rank Points Class Rank Team Surname Family name Total Stockholm Extreme 1 Karlstad Multisport Annalena Axelsson 305 2 80 Ladies 5 45 Mix Erik Pütsep 2 80 Mix Henrik Beckman 4 50 Male Christer Eriksson 4 50 Male 2 Mölndal

More information

SWEDISH CORRESPONDENTS AND PRESS OFFICERS IN THE UNITED STATES

SWEDISH CORRESPONDENTS AND PRESS OFFICERS IN THE UNITED STATES SWEDISH CORRESPONDENTS AND PRESS OFFICERS IN THE UNITED STATES September 2015 Also available online at: swedenabroad.com/washington For corrections and changes, please contact: Larilyn André Embassy of

More information

Developing a National Audit for Rheumatoid and Early Inflammatory Arthritis Ian Rowe

Developing a National Audit for Rheumatoid and Early Inflammatory Arthritis Ian Rowe Developing a National Audit for Rheumatoid and Early Inflammatory Arthritis Ian Rowe Chair Clinical Affairs Committee, BSR Outline The British Society for Rheumatology Challenges in improving patient outcomes

More information

SMF Awareness Seminar 2014

SMF Awareness Seminar 2014 SMF Awareness Seminar 2014 Clinical Evaluation for In Vitro Diagnostic Medical Devices Dr Jiang Naxin Health Sciences Authority Medical Device Branch 1 In vitro diagnostic product means Definition of IVD

More information

Translational research facilitating experimental medicine in dementia in the UK

Translational research facilitating experimental medicine in dementia in the UK Translational research facilitating experimental medicine in dementia in the UK Simon Lovestone Director Biomedical Research Unit for dementia at Maudsley and King s Route Map for Dementia Research June

More information

EMA and Progressive Multifocal Leukoencephalopathy.

EMA and Progressive Multifocal Leukoencephalopathy. EMA and Progressive Multifocal Leukoencephalopathy. ENCePP Plenary, London 23 November 2011 Presented by: Henry Fitt Head of Coordination & Networking, Pharmacovigilance & Risk Management An agency of

More information

Cancerfondens planeringsgrupp för Onkologisk Nuklidterapi meeting 2015 25-27 November 2015

Cancerfondens planeringsgrupp för Onkologisk Nuklidterapi meeting 2015 25-27 November 2015 Cancerfondens planeringsgrupp för Onkologisk Nuklidterapi meeting 2015 25-27 November 2015 Place: Lecture Hall EKEN, Entrance 65, CAMPUS US, The Faculty of Medicine and Health Science, Linköping University,

More information

MRC Technology Centre for Therapeutics Discovery

MRC Technology Centre for Therapeutics Discovery MRC Technology Centre for Therapeutics Discovery fast-tracking discovery and development of novel drugs from academia Dr Duncan Young Business Development Manager UbiFrance Symposium, October 2012 established

More information

Article 53(c) EPC - therapy

Article 53(c) EPC - therapy Article 53(c) EPC - therapy Compound X is not new, but no medical use (a) (b) (c) (d) (e) (f) (g) (h) (i) (j) (k) compound X for use as a medicament compound X for use in treating disease Y composition

More information

The NeurOmics team at a recent project meeting

The NeurOmics team at a recent project meeting Introduction Welcome to the NeurOmics project newsletter. This is the second edition and comes after the project has been underway for just over a year. This means that whilst we still have lots of work

More information

OUR MISSION. Measuring. Cataracts. Visual acuity. Level of urinary incontinence

OUR MISSION. Measuring. Cataracts. Visual acuity. Level of urinary incontinence What we do Visual acuity Level of urinary incontinence Measuring results that matter Cataracts Localized Prostate Cancer OUR MISSION We believe that better health care always starts with clinicians improving

More information

Opportunities for advancing biomarkers for patient stratification and early diagnosis in liver disease

Opportunities for advancing biomarkers for patient stratification and early diagnosis in liver disease Opportunities for advancing biomarkers for patient stratification and early diagnosis in liver disease 80 Liver Disease and Obesity Liver disease biomarkers: Percent of adult population (United States)

More information

Karolinska Institutet a medical university

Karolinska Institutet a medical university Karolinska Institutet a medical university Our mission is to contribute to the improvement of human health through research and education Blood cell. Photo by Lennart Nilsson/Scanpix Karolinska Institutet

More information

Prognosis of Patients With Breast Cancer: Causes of Death and Effects of Time Since Diagnosis, Age, and Tumor Characteristics

Prognosis of Patients With Breast Cancer: Causes of Death and Effects of Time Since Diagnosis, Age, and Tumor Characteristics Prognosis of Patients With Breast Cancer: Causes of Death and Effects of Time Since Diagnosis, Age, and Tumor Characteristics Edoardo Colzani, M.D., M.P.H. Department of Medical Epidemiology and Biostatistics

More information

EURORDIS Position Paper on Centres of Expertise and European Reference Networks for Rare Diseases

EURORDIS Position Paper on Centres of Expertise and European Reference Networks for Rare Diseases EURORDIS Position Paper on Centres of Expertise and European Reference Networks for Rare Diseases EURORDIS - the European Organisation for Rare Diseases represents 310 rare disease organisations from 34

More information

Fundraising and Research Objectives

Fundraising and Research Objectives THE EHE FOUNDATION THE EHE RARE CANCER CHARITY (UK)* THE EHE RARE CANCER FOUNDATION (AUSTRALIA)* Fundraising and Research Objectives Thank you for taking the time to find and engage with our Fundraising

More information

Autoimmune Technologies, LLC - Product Pipeline Analysis

Autoimmune Technologies, LLC - Product Pipeline Analysis Brochure More information from http://www.researchandmarkets.com/reports/1957464/ Description: Summary Autoimmune Technologies, LLC (Autoimmune) is a biomedical company, based in the US. The company develops

More information

Centre for Development and Production of Biologics

Centre for Development and Production of Biologics UTLYSNING 1 (14) Centre for Development and Production of Biologics A call for proposals under the programme Next-generation Biologics 1 Executive summary The Swedish government has given Vinnova and the

More information

STUDENT COUNCIL. Student Council spring 2011. Student Council spring 2012. Student Council autumn 2010. Student Council autumn 2011

STUDENT COUNCIL. Student Council spring 2011. Student Council spring 2012. Student Council autumn 2010. Student Council autumn 2011 STUDENT COUNCIL The student council meets every fortnight to discuss issues of common interests and to plan for coming activities. The council is formed by the students and serves as the continuous contact

More information

Immune cells from healthy people pulverise cancer

Immune cells from healthy people pulverise cancer Published on ScienceNordic (http://sciencenordic.com) Home > Printer-friendly PDF > Printer-friendly PDF Immune cells from healthy people pulverise cancer Health[1] Health[1]Cancer research [2]immune system

More information

BIOSCIENCES COURSE TITLE AWARD

BIOSCIENCES COURSE TITLE AWARD COURSE TITLE AWARD BIOSCIENCES As a Biosciences undergraduate student at the University of Westminster, you will benefit from some of the best teaching and facilities available. Our courses combine lecture,

More information

Karolinska Institutet a medical university

Karolinska Institutet a medical university Karolinska Institutet is one of the world s leading medical universities. Its vision is to significantly contribute to the improvement of human health. Karolinska Institutet accounts for over 40 per cent

More information

Haematological cancers: improving outcomes

Haematological cancers: improving outcomes Haematological cancers: improving outcomes Consultation on draft scope Stakeholder comments table 14/04/15 to 30/04/15 ID Stakeholder Page 3 Roche General General Specific consideration should be given

More information

EURORDIS-NORD-CORD Joint Declaration of. 10 Key Principles for. Rare Disease Patient Registries

EURORDIS-NORD-CORD Joint Declaration of. 10 Key Principles for. Rare Disease Patient Registries EURORDIS-NORD-CORD Joint Declaration of 10 Key Principles for Rare Disease Patient Registries 1. Patient Registries should be recognised as a global priority in the field of Rare Diseases. 2. Rare Disease

More information

Clinical Research from EHR data

Clinical Research from EHR data Clinical Research from EHR data Gunnar O Klein professor in Health Informatics at NSEP Norwegian Centre for EHR Research Workshop at HelseIT in Trondheim 2012-09-19 1 Purpose of the workshop Together with

More information

New strategies in the field of rare diseases: a comprehensive international approach Runolfur Palsson

New strategies in the field of rare diseases: a comprehensive international approach Runolfur Palsson 17 January 2012 Annual Conference of the Icelandic Medical Association New strategies in the field of rare diseases: a comprehensive international approach Runolfur Palsson Rare diseases In Europe, a disease

More information

Stem cell research ACADEMY STATEMENT. progress, hopes and concerns ACADEMY STATEMENT 16 JANUARY 2013

Stem cell research ACADEMY STATEMENT. progress, hopes and concerns ACADEMY STATEMENT 16 JANUARY 2013 ACADEMY STATEMENT 16 JANUARY 2013 ACADEMY STATEMENT Stem cell research progress, hopes and concerns KUNGL. VETENSKAPSAKADEMIEN, BOX 50005, SE-104 05 STOCKHOLM, SWEDEN TEL +46 8 673 95 00, FAX +46 8 15

More information

The History of MS Research Points the Way to the Future

The History of MS Research Points the Way to the Future The History of MS Research Points the Way to the Future Substantial progress has been made in developing MS therapeutics. However, successfully treating MS continues to present great challenges. Treatment

More information

phealthlab, a need for effective phealthcare!

phealthlab, a need for effective phealthcare! phealthlab, a need for effective phealthcare! Define an unmet need! Provide a simple solution for the user!! Lars-Olof Hansson Karolinska University Laboratory Karolinska Institution Stockholm, Sweden

More information

Diagnostic Detectives: Medical Laboratory Professionals. A Closer Look at Careers in Clinical Laboratory Science (Medical Technology)

Diagnostic Detectives: Medical Laboratory Professionals. A Closer Look at Careers in Clinical Laboratory Science (Medical Technology) Diagnostic Detectives: Medical Laboratory Professionals A Closer Look at Careers in Clinical Laboratory Science (Medical Technology) Medical Laboratory Facts A behind-the the-scenes, highly skilled team

More information

Hacking Brain Disease for a Cure

Hacking Brain Disease for a Cure Hacking Brain Disease for a Cure Magali Haas, CEO & Founder #P4C2014 Innovator Presentation 2 Brain Disease is Personal The Reasons We Fail in CNS Major challenges hindering CNS drug development include:

More information

Highlights of Prostate Cancer Research in Ireland

Highlights of Prostate Cancer Research in Ireland Highlights of Prostate Cancer Research in Ireland Prostate Cancer Research Consortium Five years of working together 2004-2009 1. Prostate Cancer in Ireland Each year in Ireland about 2,500 men are diagnosed

More information

A summary of. Strategy Roadmap for Karolinska Institutet STRATEGY

A summary of. Strategy Roadmap for Karolinska Institutet STRATEGY A summary of Strategy 2018 Roadmap for Karolinska Institutet 2014 2018 STRATEGY 2018 1 Only through everyone s participation can we attain the ambitious and concrete goals outlined in the strategy READ

More information

Patient Centricity and the Changing Landscape of Healthcare

Patient Centricity and the Changing Landscape of Healthcare Patient Centricity and the Changing Landscape of Healthcare Andrea Cotter Director Healthcare Marketing IBM Corporation IBM Healthcare and Life Sciences Patient Centricity and the Changing Landscape of

More information

2009 28-29, September. Program & Meeting Attendees

2009 28-29, September. Program & Meeting Attendees 2009 28-29, September Swedish Malaria Network Annual Conference 2009 Program & Meeting Attendees Sigtuna foundation's Guest-House Program Day 1, Monday, September 28 11:00-11:45 Registration/information

More information

Clinical trials: The EU perspective. Dr Karim Berkouk, Deputy Head of Unit DG for Research and Innovation Health Directorate European Commission

Clinical trials: The EU perspective. Dr Karim Berkouk, Deputy Head of Unit DG for Research and Innovation Health Directorate European Commission Clinical trials: The EU perspective Dr Karim Berkouk, Deputy Head of Unit DG for Research and Innovation Health Directorate European Commission Content 1.EU: The global picture 2.EU & Clinial trials: The

More information

WELCOME TO THE 12 TH LURN RETREAT APRIL 15 16, 2015 YSTAD SALTSJÖBAD, YSTAD

WELCOME TO THE 12 TH LURN RETREAT APRIL 15 16, 2015 YSTAD SALTSJÖBAD, YSTAD WELCOME TO THE 12 TH LURN RETREAT APRIL 15 16, 2015 YSTAD SALTSJÖBAD, YSTAD ORGANIZING COMMITTEE: Gunilla Westergren Thorsson, Leif Bjermer, Arne Egesten, Jonas Erjefält, Claes Göran Löfdahl, Roland Andersson,

More information

Nutrition and Toxicants in Autoimmune Disease: Implications for Prevention and Treatment

Nutrition and Toxicants in Autoimmune Disease: Implications for Prevention and Treatment Nutrition and Toxicants in Autoimmune Disease: Implications for Prevention and Treatment Collaborative on Health and the Environment June 17, 2014 Ted Schettler MD, MPH 1 Autoimmune diseases Autoimmunity

More information

How You Can Help Medical Research

How You Can Help Medical Research National Cancer Institute U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health How You Can Help Medical Research Donating Your Blood, Tissue, and Other Samples You have the choice

More information

LIFE SCIENCES QUEENSLAND LIMITED (LSQ) Mario Pennisi CEO. @LSQld

LIFE SCIENCES QUEENSLAND LIMITED (LSQ) Mario Pennisi CEO. @LSQld LIFE SCIENCES QUEENSLAND LIMITED (LSQ) Mario Pennisi CEO @LSQld LEADING DESTINATION FOR CLINICAL RESEARCH INVESTORS IN QLD INCLUDE: LIFE SCIENCES IN QLD ~300 companies in life sciences ~$5B invested by

More information

Welcome to the Launch of Biocon s Breakthrough Innovation. For Psoriasis. Treatment

Welcome to the Launch of Biocon s Breakthrough Innovation. For Psoriasis. Treatment Welcome to the Launch of Biocon s Breakthrough Innovation For Psoriasis Treatment PRESS MEET Bangalore, August 10, 2013 Autoimmune Diseases are on the Rise Globally Autoimmune Disease Segment includes

More information

Launching Defeating MS Together The European Code of Good Practice in MS. Dr Alexis Willett & Prof Gavin Giovannoni

Launching Defeating MS Together The European Code of Good Practice in MS. Dr Alexis Willett & Prof Gavin Giovannoni Launching Defeating MS Together The European Code of Good Practice in MS Dr Alexis Willett & Prof Gavin Giovannoni Outline 1. Background 2. Activity since the original Code 3. Revision process 4. Key features

More information

TABLE OF CONTENTS. Introduction...1. Chapter1 AdvancesinTreatment...2. Chapter2 MedicinesinDevelopment...11. Chapter3 ValueandSpending...

TABLE OF CONTENTS. Introduction...1. Chapter1 AdvancesinTreatment...2. Chapter2 MedicinesinDevelopment...11. Chapter3 ValueandSpending... CANCER TABLE OF CONTENTS Introduction...1 Chapter1 AdvancesinTreatment...2 Chapter2 MedicinesinDevelopment......11 Chapter3 ValueandSpending......15 Chapter4 Conclusion...22 INTRODUCTION Researchers and

More information

Global Monoclonal Antibodies Pipeline Insight 2015

Global Monoclonal Antibodies Pipeline Insight 2015 Brochure More information from http://www.researchandmarkets.com/reports/3113388/ Global Monoclonal Antibodies Pipeline Insight 2015 Description: Ever since the Nobel Prize was bestowed on the person who

More information

Clinical Research Infrastructure at the European level: the ECRIN model. Christine Kubiak ECRIN Coordination Inserm- DRCT

Clinical Research Infrastructure at the European level: the ECRIN model. Christine Kubiak ECRIN Coordination Inserm- DRCT Clinical Research Infrastructure at the European level: the RIN model Christine Kubiak RIN Coordination Inserm- DRCT Finland FinnCRIN Ireland ICRIN UK UKCRN France Inserm Denmark DCRIN Germany KKS Switzerland

More information

Quality and Safety Evaluation of Gene Therapy Products in Japan

Quality and Safety Evaluation of Gene Therapy Products in Japan Quality and Safety Evaluation of Gene Therapy Products in Japan Review Mechanism for Gene Therapy in Japan The review mechanism for gene therapy in Japan was partially amended to simplify the necessary

More information

Personalised Healthcare Frequently Asked Questions

Personalised Healthcare Frequently Asked Questions Personalised Healthcare Frequently Asked Questions Foreword In one sense, personalised healthcare is nothing new. It is what doctors have aimed to provide for their patients through the exercise of their

More information

Draft GDPR and health-related scientific research: Where do we stand with the EU Council?

Draft GDPR and health-related scientific research: Where do we stand with the EU Council? Draft GDPR and health-related scientific research: Where do we stand with the EU Council? Gauthier Chassang, Lawyer BIOBANQUES Infrastructure, INSERM US013, France Data Protection for health: Enabling

More information

Biotherapeutic Medicines

Biotherapeutic Medicines International Federation of Pharmaceutical Manufacturers & Associations Biotherapeutic Medicines Grasping the New Generation of Treatments Biotherapeutic medicines are an integral and valuable part of

More information

IV ESBB Annual Meetin Leipzig, October, 201. Manuel M Morente Spanish National Cancer Research Centre CNIO Spanish National Biobank Network

IV ESBB Annual Meetin Leipzig, October, 201. Manuel M Morente Spanish National Cancer Research Centre CNIO Spanish National Biobank Network IV ESBB Annual Meetin Leipzig, October, 201 Manuel M Morente Spanish National Cancer Research Centre CNIO Spanish National Biobank Network Biobanker Where biobankers comes from We need to prepare a new

More information

P4 Medicine: Personalized, Predictive, Preventive, Participatory A Change of View that Changes Everything

P4 Medicine: Personalized, Predictive, Preventive, Participatory A Change of View that Changes Everything P4 Medicine: Personalized, Predictive, Preventive, Participatory A Change of View that Changes Everything Leroy E. Hood Institute for Systems Biology David J. Galas Battelle Memorial Institute Version

More information

Us TOO University Presents: Understanding Diagnostic Testing

Us TOO University Presents: Understanding Diagnostic Testing Us TOO University Presents: Understanding Diagnostic Testing for Prostate Cancer Patients Today s speaker is Manish Bhandari, MD Program moderator is Pam Barrett, Us TOO International Made possible by

More information

www.uea.ac.uk/pha WHAT WILL YOU DISCOVER?

www.uea.ac.uk/pha WHAT WILL YOU DISCOVER? www.uea.ac.uk/pha WHAT WILL YOU DISCOVER? PHARMACOLOGY AND DRUG DISCOVERY UNDERGRADUATE COURSES 2016 WELCOME JOIN US ON A UNIQUE COURSE DESIGNED TO PRODUCE THE UK S NEXT LEADERS IN DRUG DISCOVERY. 1 1

More information

IMI2: why, what, how?

IMI2: why, what, how? IMI2: why, what, how? The Right prevention and treatment, to the right patient, at the right time Isabelle Thizon-de Gaulle VP, Strategic initiatives & Scientific relations Sanofi R&D Innovative Medicines

More information

The Molecular Diagnostic Market and development of personalized molecular tests

The Molecular Diagnostic Market and development of personalized molecular tests The Molecular Diagnostic Market and development of personalized molecular tests Dr. Iris Simon Sr. Director Research & Development, Agendia NV, Amsterdam NL and Irvine CA Agendia - Who are we Molecular

More information

AREAS EMPLOYERS STRATEGIES/INFORMATION PHYSICAL THERAPY

AREAS EMPLOYERS STRATEGIES/INFORMATION PHYSICAL THERAPY HEALTHCARE SCIENCES Physical & Occupational Therapy, Cytotechnology, Dental Hygiene, Health Information Management, Clinical Laboratory Science What can I do with these degrees? PHYSICAL THERAPY Physical

More information

A leader in the development and application of information technology to prevent and treat disease.

A leader in the development and application of information technology to prevent and treat disease. A leader in the development and application of information technology to prevent and treat disease. About MOLECULAR HEALTH Molecular Health was founded in 2004 with the vision of changing healthcare. Today

More information

Strategies for cancer care in Sweden

Strategies for cancer care in Sweden Strategies for cancer care in Sweden Bo Lindblom National Board of Health and Welfare Stockholm, Sweden Commission of inquiry 2007-2009 Principal investigator: DG Kerstin Wigzell Committee members Long

More information

Chromosomal analysis for prenatal samples, peripheral blood, bone marrow biopsy samples, various types of lymphomas, and solid tumors

Chromosomal analysis for prenatal samples, peripheral blood, bone marrow biopsy samples, various types of lymphomas, and solid tumors Chromosomal analysis for prenatal samples, peripheral blood, bone marrow biopsy samples, various types of lymphomas, and solid tumors FISH (fluorescence in situ hybridization) assays and many probes that

More information

European Research Infrastructure Bio-Banking and Biomolecular Resources. SC Telephone Conference call August 25 th, 2010 at 9:00-10:00 Draft Minutes

European Research Infrastructure Bio-Banking and Biomolecular Resources. SC Telephone Conference call August 25 th, 2010 at 9:00-10:00 Draft Minutes European Research Infrastructure Bio-Banking and Biomolecular Resources SC Telephone Conference call August 25 th, 2010 at 9:00-10:00 Draft Minutes Members present:, Georges Dagher (GD), Martin Fransson

More information

Human Research Protection Program University of California, San Diego ISSUES ON DNA AND INFORMED CONSENT

Human Research Protection Program University of California, San Diego ISSUES ON DNA AND INFORMED CONSENT Human Research Protection Program University of California, San Diego ISSUES ON DNA AND INFORMED CONSENT Regulatory changes will occur for investigators studying human DNA The recent acceleration and widening

More information

www.biobankcloud.com Jim Dowling KTH Royal Institute of Technology, Stockholm SICS Swedish ICT CSHL Meeting on Biological Data Science, 2014

www.biobankcloud.com Jim Dowling KTH Royal Institute of Technology, Stockholm SICS Swedish ICT CSHL Meeting on Biological Data Science, 2014 www.biobankcloud.com Jim Dowling KTH Royal Institute of Technology, Stockholm SICS Swedish ICT CSHL Meeting on Biological Data Science, 2014 Definition of a Biobank The Biobank concept is defined (by Swedish

More information

Focus Biobank Inflammatory Bowel Disease

Focus Biobank Inflammatory Bowel Disease Focus Biobank Inflammatory Bowel Disease University Hospitals Leuven KU Leuven Isabelle Cleynen, PhD Inflammatory Bowel Disease Crohn s disease (CD) Entire GI tract Transmural Fistulas and/or strictures

More information

Lars Lundquist assigns the recording of the minutes of the AGM to Maria Bäckman, JM's Chief Legal Advisor.

Lars Lundquist assigns the recording of the minutes of the AGM to Maria Bäckman, JM's Chief Legal Advisor. TRANSLATION OF THE ORIGINAL TEXT IN SWEDISH Minutes of the Annual General Meeting of JM AB in Solna Tuesday, April 21, 2015 1. Call to order and election of Chairperson The Annual General Meeting (AGM)

More information

Bad Bugs - Future Drugs? Innovations under development that can supplement the traditional use of antibiotics

Bad Bugs - Future Drugs? Innovations under development that can supplement the traditional use of antibiotics Bad Bugs - Future Drugs? Innovations under development that can supplement the traditional use of antibiotics Foreword The Swedish Government, through the Ministry of Enterprise, Energy and Communications,

More information

Novel therapeutic approaches in multiple sclerosis Neuroprotective and remyelinating agents, the future of clinical trials in MS?

Novel therapeutic approaches in multiple sclerosis Neuroprotective and remyelinating agents, the future of clinical trials in MS? Novel therapeutic approaches in multiple sclerosis Neuroprotective and remyelinating agents, the future of clinical trials in MS? Marie Trad, M.D., Lynne Hughes, Cathy VanBelle, Amy Del Medico 3rd International

More information

Hodgkin Lymphoma Disease Specific Biology and Treatment Options. John Kuruvilla

Hodgkin Lymphoma Disease Specific Biology and Treatment Options. John Kuruvilla Hodgkin Lymphoma Disease Specific Biology and Treatment Options John Kuruvilla My Disclaimer This is where I work Objectives Pathobiology what makes HL different Diagnosis Staging Treatment Philosophy

More information

SAVE A LIFE... BY GIVING LIFE! Information guide and registration Héma-QUEBEC PUBLIC CORD BLOOD BANK

SAVE A LIFE... BY GIVING LIFE! Information guide and registration Héma-QUEBEC PUBLIC CORD BLOOD BANK SAVE A LIFE... BY GIVING LIFE! Information guide and registration Héma-QUEBEC PUBLIC CORD BLOOD BANK Table of contents Introduction... 2 History of the Public Cord Blood Bank... 3 Transplantation and

More information

CANADIAN RULE BASED CLASSIFICATION SYSTEM (IVDD) Life Sciences British Columbia NRC-Industry Research Assistance Program

CANADIAN RULE BASED CLASSIFICATION SYSTEM (IVDD) Life Sciences British Columbia NRC-Industry Research Assistance Program CANADIAN RULE BASED CLASSIFICATION SYSTEM (IVDD) Life Sciences British Columbia NRC-Industry Research Assistance Program Health Canada Regulations on Medical Devices Vancouver, B.C. October 29, 2007 Nancy

More information

Roche Position on Human Stem Cells

Roche Position on Human Stem Cells Roche Position on Human Stem Cells Background Stem cells and treating diseases. Stem cells and their applications offer an enormous potential for the treatment and even the cure of diseases, along with

More information

Swedish Initiative for Research on Microdata in the Social And Medical Sciences

Swedish Initiative for Research on Microdata in the Social And Medical Sciences Swedish Initiative for Research on Microdata in the Social And Medical Sciences www.simsam.nu GOCARTS Kardiovaskulär epidemiologi hjärtinfarkt och stroke www.registerforskning.se GOCARTs (Gothenburg CArdiovascular

More information

Data in biobanking An emerging new era for data management

Data in biobanking An emerging new era for data management 3. Main Topic DATA (Sessions C1-5) Data in biobanking An emerging new era for data management Medical University of Graz 21 / 43 C1 - Medical imaging and biobanking (radiology and digital pathology) Jan-Eric

More information

INFORMATION LEAFLET. If anything is not clear, or if you would like more information, please

INFORMATION LEAFLET. If anything is not clear, or if you would like more information, please BIO INFOBK 1492 0410:Layout 1 21/04/2010 15:24 Page 1 INFORMATION LEAFLET You are being invited to take part in a major medical research project called UK Biobank. The purpose of UK Biobank is to set up

More information

STEERING COMMITTEE FOR THE UK STEM CELL BANK AND FOR THE USE OF STEM CELL LINES

STEERING COMMITTEE FOR THE UK STEM CELL BANK AND FOR THE USE OF STEM CELL LINES THIS PAGE MAY BE REMOVED BEFORE SUBMISSION STEERING COMMITTEE FOR THE UK STEM CELL BANK AND FOR THE USE OF STEM CELL LINES tes to Depositors APPLICATION FORM TO DEPOSIT A HUMAN STEM CELL LINE IN THE UK

More information

Narrator: Transplants using stem cells from the blood, bone marrow or umbilical cord blood

Narrator: Transplants using stem cells from the blood, bone marrow or umbilical cord blood [Track 2: What Is a Transplant?] Narrator: Transplants using stem cells from the blood, bone marrow or umbilical cord blood can be an effective treatment for people with blood cancers such as leukemia,

More information

Final announcement Joint meeting in Radiation Biology and Radioecology

Final announcement Joint meeting in Radiation Biology and Radioecology Final announcement Joint meeting in Radiation Biology and Radioecology For the Association for Radiation Research in UK, the Swedish Radiobiology Society, the Netherlands Radiobiological Society and the

More information

ALLIED HEALTH. Clinical Practice Acute care Neuro-rehab Out-patient Management Education Research Consultation

ALLIED HEALTH. Clinical Practice Acute care Neuro-rehab Out-patient Management Education Research Consultation ALLIED HEALTH Physical & Occupational Therapy, Cytotechnology, Dental Hygiene, Health Information Management, Medical Technology What can I do with these degrees? PHYSICAL THERAPY Physical therapy involves

More information

PARTICIPANT INFORMATION

PARTICIPANT INFORMATION PARTICIPANT INFORMATION IMPERIAL POPULATION BIORESOURCE TISSUE BANK (PART OF NIHR BIORESOURCE) In the UK around 20 million people are said to be living with a long-term condition such as diabetes or heart

More information

20 Years Swedish Legal Integration in the EU: A Two-way Street Conference Program. February 16-17, 2015 THE SWEDISH NETWORK FOR EUROPEAN LEGAL STUDIES

20 Years Swedish Legal Integration in the EU: A Two-way Street Conference Program. February 16-17, 2015 THE SWEDISH NETWORK FOR EUROPEAN LEGAL STUDIES THE SWEDISH NETWORK FOR EUROPEAN LEGAL STUDIES HAS THE GREAT PLEASURE OF INVITING YOU TO AN INTERNATIONAL CONFERENCE ON: 20 Years Swedish Legal Integration in the EU: A Two-way Street Conference Program

More information

Living Donor Paired Exchange Registry. What is Living Kidney Donor Paired Exchange?

Living Donor Paired Exchange Registry. What is Living Kidney Donor Paired Exchange? Living Paired Exchange Registry What is Living Kidney Paired Exchange? The Living Paired Exchange Registry. At Canadian Blood Services, we are committed to helping Canadians help each other. By building

More information

Global Rheumatoid Arthritis Market: Trends and Opportunities (2013-2018)

Global Rheumatoid Arthritis Market: Trends and Opportunities (2013-2018) Brochure More information from http://www.researchandmarkets.com/reports/2693611/ Global Rheumatoid Arthritis Market: Trends and Opportunities (2013-2018) Description: The report titled 'Global Rheumatoid

More information

Clinically Actionable Biomarkers in Rheumatoid Arthritis

Clinically Actionable Biomarkers in Rheumatoid Arthritis Clinically Actionable Biomarkers in Rheumatoid Arthritis PepTalk January 6, 2009 William Robinson, MD, PhD Stanford University School of Medicine VA Palo Alto Health Care System T cell mediated Autoimmune

More information

The History of MS Research Points the Way to the Future

The History of MS Research Points the Way to the Future Here at ACP we tend to focus forward, on research and data analysis that will improve future treatments for people with MS and one day uncover a cure. But sometimes it s useful, even interesting, to look

More information

LifeLines Cohort Study. Salome Scholtens, Manager Research Office

LifeLines Cohort Study. Salome Scholtens, Manager Research Office LifeLines Cohort Study Salome Scholtens, Manager Research Office What is LifeLines? Biobank» LifeLines Cohort & Biorepository 165,000 participants at least 30 years follow-up Three generation design Northern

More information

TRENDS SHAPING THE FUTURE OF PERSONALIZED CARE AND THE DELIVERY OF SPECIALTY PHARMACY

TRENDS SHAPING THE FUTURE OF PERSONALIZED CARE AND THE DELIVERY OF SPECIALTY PHARMACY TRENDS SHAPING THE FUTURE OF PERSONALIZED CARE AND THE DELIVERY OF SPECIALTY PHARMACY Key Takeaways from the June 18, 2013 Regional Symposium Nashville, Tennessee THE SYMPOSIUM Trends Shaping the Future

More information

Global Multiple Sclerosis Epidemiology and Patient Flow Analysis - 2015

Global Multiple Sclerosis Epidemiology and Patient Flow Analysis - 2015 Brochure More information from http://www.researchandmarkets.com/reports/3070277/ Global Multiple Sclerosis Epidemiology and Patient Flow Analysis - 2015 Description: The author announced the results of

More information